Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

A Body Scan for Cancer Detection using Quantum Technology

Descripción del proyecto

Detección innovadora del cáncer de mama basada en las tecnologías óptica y cuántica

El cáncer es la segunda causa principal de muerte en el mundo y el cáncer de mama figura entre los tipos más habituales. El proyecto financiado con fondos europeos CANCER SCAN está desarrollando un método innovador de detección de cáncer de mama basado en las tecnologías óptica y cuántica, pensado para mejorar el diagnóstico con una exposición mínima a la radiación. El concepto innovador conlleva el uso no invasivo de luz y la transmisión y detección unificada de fotones en el espacio multidimensional, lo cual permite que el escáner detecte de forma simultánea tumores en todas la partes del cuerpo con un riesgo mínimo de radiación. El proyecto piloto se centra en la detección temprana del cáncer de mama, ya que el desarrollo de un método diagnóstico fiable y mejorado es de suma importancia, dada la prevalencia de esta enfermedad.

Objetivo

We propose to develop a radically new unified technological concept of biomedical detection utilizing front line new ideas in quantum optics and quantum mechanics. The new concept will be based on unified transmission and detection of photons in a three dimensional space of orbital angular momentum, entanglement and hyper-spectral characteristics (OES). These will enable a revolutionary scanner capable of detecting cancer not only in a specified organ but in various parts of the body at once, even from remote locations, and with no radiation risk whatsoever. Our pilot project will be focused on the early detection of breast cancer. Mammography, as the state of the art method for breast cancer screening, is limited in its sensitivity especially in younger women and/or women with dense breasts, and has been found to be problematic in women with genetic mutations. Thus the development of an improved and more reliable detection method is of paramount importance. A novel detection algorithm will be developed based on clinical trials in breast cancer patients, using the unified transmission and detection theory. We chose to verify our concept in the area of breast cancer due to its prevalence and the condition that feeds our concept (large amount of tissue without bone). In the long term this approach can be adapted to other areas of bio-medical diagnostics leading to total mass screening. The concept is based on non invasive utilization of light and its ramifications are numerous.
In the proposed project, the endeavor will be both theoretical and experimental including derivation of a mathematical
model and development of an experimental bio-compatible test-bed for cancer detection with minimal false positives.
Our joint knowledge places the project at the cutting edge of science and technology developing a novel technology with the
long-term vision of integrating quantum science in medical applications.

Convocatoria de propuestas

H2020-FETOPEN-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-FETOPEN-2018-2019-2020-01

Régimen de financiación

RIA - Research and Innovation action

Coordinador

BEN-GURION UNIVERSITY OF THE NEGEV
Aportación neta de la UEn
€ 1 297 300,00
Coste total
€ 1 297 300,00

Participantes (3)